A Study of LY3045697 in Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

27

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

LY3045697

Administered orally

DRUG

Placebo

Administered orally

Trial Locations (1)

Unknown

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., Zuidlaren

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT01750853 - A Study of LY3045697 in Healthy Participants | Biotech Hunter | Biotech Hunter